IRLAB Therapeutics AB (OSTO:IRLAB A) Stock News, Headlines & Updates
IRLAB Therapeutics AB Stock News from GuruFocus
- 1
Jul 10, 2024
IRLAB Publishes Interim Report for the Period January-June 2024
ACCESSWIRE • 3:00am
Jul 08, 2024
IRLAB: Invitation to the Interim Report for Q2 2024 Presentation and Webcast
ACCESSWIRE • 3:00am
Jul 02, 2024
IRLAB's Phase IIb Study of Pirepemat Can Proceed as Planned after Positive Opinion from External Safety Committee
ACCESSWIRE • 3:00am
Jun 11, 2024
IRLAB Participates in Stora Aktiedagarna
ACCESSWIRE • 3:00am
May 28, 2024
IRLAB Presents at Redeye Growth Day 30 May
ACCESSWIRE • 3:00am
May 27, 2024
IRLAB Appoints Kristina Torfgård as New CEO
ACCESSWIRE • 3:00am
May 23, 2024
IRLAB Strengthens its Liquidity by Drawing SEK 25 million on a Previously Secured Loan Facility
ACCESSWIRE • 11:00am
May 22, 2024
Report from the Annual General Meeting 2024 of IRLAB Therapeutics AB
ACCESSWIRE • 3:00pm
IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757
ACCESSWIRE • 7:00am
IRLAB broadcasts the Annual General Meeting Live
ACCESSWIRE • 3:00am
May 21, 2024
IRLAB Presents at ABGSC Investor Days
ACCESSWIRE • 3:00am
May 08, 2024
IRLAB Publishes Interim Eeport for the Period January-March 2024
ACCESSWIRE • 3:00am
May 07, 2024
IRLAB Enters a Development Collaboration for IRL757 as a Novel Treatment for Apathy
ACCESSWIRE • 11:00am
May 06, 2024
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757
ACCESSWIRE • 3:00am
IRLAB: Invitation to the Interim Report for Q1 2024 Presentation and Webcast
ACCESSWIRE • 3:00am
Apr 29, 2024
IRLAB publishes Annual Report for 2023
ACCESSWIRE • 3:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news